The parasitic protozoan Toxoplasma gondii and its relatives (e.g. Plasmodium spp., which cause malaria) constitute a major global health problem. In recent years, the elucidation of biological processes in these parasites has accelerated with the application of genetic and genomic methodologies. Genetic analyses in T. gondii have revealed a remarkably stable 87 Mb (megabase) nuclear genome consisting of 11 chromosomes showing little variation across strains. Population studies demonstrate that the small amount of variation defines three clonal lineages where phenotypes such as virulence are associated with a single lineage. The random generation of cDNA (complementary DNA) sequences derived from different strains and developmental stages has highlighted the genetic differences underlying observed phenotypic variation. T. gondii also contains an extrachromosomal 35 kb (kilobase) circular DNA within an organelle with plastid-like properties. The limited coding capacity of the 35 kb organellar genome suggests that proteins responsible for organelle function(s) must be encoded by the nucleus. Scrutiny of T. gondii nuclear cDNA sequences has uncovered a number of proteins thought to carry out essential roles in the organelle (e.g. fatty acid biosynthesis). The synergism between these seemingly unrelated genomic studies has provided a greater understanding of parasite pathogenesis and has identified several new targets for chemotherapy.
Parasitic protozoa of the phylum Apicomplexa, including Plasmodium spp. (which cause malaria), Eimeria spp. (which cause avian coccidiosis) and Toxoplasma gondii, represent a major source of human and animal disease worldwide. T. gondii is the cause of significant morbidity and mortality in patients who have AIDS (acquired immunodeficiency syndrome) and serious congenital birth defects in both humans and livestock (Refs 1, 2). Although infection is usually asymptomatic in healthy individuals, immunocompromised patients often suffer from a life-threatening encephalitis (Ref. 2) . Currently, the combination of pyrimethamine and sulphadiazine is the treatment of choice for noncongenital toxoplasmosis. Unfortunately, owing to the toxic side effects and general low efficacy of these and other known parasiticidal drugs, new chemotherapeutic agents are urgently required (Refs 2, 3).
Genomic research on apicomplexan parasites, including genomic sequencing projects (for example, see Ref. 4) , has generated a wealth of information that will undoubtedly lead to new therapies for these diseases. The genomes of these parasites, like those of other eukaryotic cells, are composed of both nuclear and organellar DNA. T. gondii contains a nuclear genome of about 87 Mb, a 6 kb mitochondrial genome, and an episomal 35 kb plastid-like genome (Ref. 5) . T. gondii has emerged as the premier model apicomplexan because in vivo or in vitro isolation and/or culture of the asexual life-cycle stages is possible, and it has a well-characterised cell biology and established genetics (see for example Ref. 6) . Not surprisingly, genomic investigations on T. gondii have both exploited and facilitated research in these areas, leading to some unexpected discoveries.
Population genetic analysis of nucleotide polymorphisms has divided the species into three closely related clonal lineages with corresponding phenotypic differences (Ref. 7) . In stark contrast to the chromosomal complexities of other protozoan parasites, the congruence of karyotype and genetic linkage mapping defines exactly 11 nuclear chromosomes for the species (Refs 8, 9). Single-pass DNA sequencing of random cDNAs, also known as expressed sequence tags (ESTs; Ref. 10) , from strain-and stage-specific cDNA libraries has generated a wealth of data for gene identification and the assessment of gene expression (Refs 11, 12) . A novel use of these sequences has been the identification and analysis of nucleus-encoded proteins of the plastid-like organelle found in many members of the Apicomplexa (Ref. 13 ). The discovery of this plastid-like organelle, now referred to as the apicoplast, followed the realisation that the 35 kb circular DNA is homologous to plastid genomes of photosynthetic organisms (Refs 14, 15) . The complete sequence and analysis of the apicoplast genome of T. gondii has provided new insight into the taxonomic relationships of the organelle and its potential as a drug target (Ref. 16 ; J.C. Kissinger et al., Department of Biology, University of Pennsylvania, Philadelphia, PA, USA, pers. commun.; GenBank accession number U87145; http://www.sas.upenn.edu/~jkissing/ toxomap.html). Collectively, these studies suggest that strain type, organellar function and communication with the nucleus probably play a vital role in the developmental changes and consequent disease pathology of T. gondii.
Pathogenesis
The obligate intracellular pathogen T. gondii is unique among apicomplexans because it can invade and multiply in the nucleated cells of virtually all warm-blooded animals (Ref. 1) . The sequential release of proteins from the three major secretory organelles, namely the micronemes, rhoptries and dense granules (Ref. 17 ; http:// webs.cb.uga.edu/~striepen/gfp.html), appears to facilitate host cell attachment, invasion and generation of the parasitophorous vacuole (Refs 18, 19; Fig. 1 ). The parasitophorous vacuole provides a safe environment for the parasite to multiply, because it is resistant to acidification and lysosomal fusion (Refs 20, 21, 22, 23) . Although sexual reproduction occurs exclusively in the definitive host (members of the cat family), secondary hosts (including humans) can participate in an indefinite cycle of asexual reproduction via infection and carnivory (i.e. by eating undercooked meat; Ref. 1; Fig. 2 ). Mice are thought to be an important natural secondary host and serve as the model system of choice for studies of pathogenesis. The acute disease phase is associated with the rapidly dividing form or 'tachyzoite', and the chronic phase with the presence of parasite tissue cysts containing the slowly dividing form or 'bradyzoite'. The tissue cysts can persist for the life of the host with no apparent ill-effects in healthy individuals. A significant proportion of the adult human Figure 1 . Ultrastructure of a Toxoplasma gondii tachyzoite. The conoid defines the apical end of the parasite and is thought to be associated with the penetration of the host cell. Micronemes, rhoptries and dense granules are the three major secretory organelles, found predominately at the apical end of the parasite. Microneme proteins are released very early in the invasion process, facilitating host-cell binding and gliding motility. Rhoptry proteins are also released during invasion, and can be detected within the lumen and membrane of the newly generated parasitophorous vacuole (PV). Dense-granule proteins are released during and after the formation of the PV, modifying the PV environment for intracellular survival and replication of the parasite. The apicoplast is a plastid-like four-membrane organelle containing a 35 kb circular DNA. Most of the proteins functioning within the organelle are encoded by the nucleus, and are specifically targeted to the apicoplast. This targeting involves the secretory pathway, including the rough endoplasmic reticulum (ER) and a Golgi body situated immediately apical to the nucleus. Targeted proteins have a bipartite N-terminal extension, consisting of an ER signal sequence followed by a plastid transit peptide. T. gondii cells have a single nucleus and a single mitochondrion. It is hypothesised that reliance on the mitochondrion for cellular metabolism differs according to the life-cycle stage of the parasite (fig001jac). population has been infected by the parasite, depending on lifestyle and geographic locale. For example, it is thought that the lower infection rate in the UK (30-40%) compared with France (60-90%) may be due to differences in the consumption of rare or undercooked meat (Ref. 1).
Although human infections are usually relatively benign and lead to lifelong immunity, acute T. gondii infection during pregnancy in the nonimmune host can cause congenital transmission resulting in serious birth defects (affecting up to 0.1% of live births in some locations; Refs 24, 25) . Furthermore, the reactivation of a latent chronic infection in an immunocompromised host can cause a lifethreatening encephalitis; thus, T. gondii is a major contributor to AIDS-related disease (Ref. 2) . Unfortunately, chemotherapeutic treatment of an active acute infection does not prevent recurrence at a later date, so many immunocompromised patients require long-term prophylactic treatment. From a clinical standpoint, the elucidation of the mechanisms leading to the establishment and maintenance of a chronic infection is of paramount importance because no therapy currently exists to treat this stage of the disease (Refs 2, 26).
Genetics and the nuclear genome
Genomic studies necessarily include basic genetic information for both experimental design and downstream data analysis. Population and genetic linkage studies of T. gondii provide a robust framework for genomic analysis because they define the range of heritable and phenotypic differences between strains. For disease pathology, differences in the ability of strains to establish a chronic infection is the principal observation upon which most of the genomic studies are based. 
Genomic analysis
The T. gondii genome consists of three DNA components, located in the nucleus, apicoplast and mitochondrion. The nuclear genome is haploid for most of the parasite's life cycle, except for a brief diploid phase in the cat intestine before meiosis (Ref. 31 ). The haploid DNA content is estimated to be 87 Mb, and linkage analysis of approximately 80 polymorphic loci in a cross between a clone of ME49 (a Type II strain) and CEP (a Type III strain) has defined 11 linkage groups with a total of 147 centimorgans (Ref. 8 ).
The chromosomes do not condense during mitosis, so the karyotype has been determined by pulsed-field gel electrophoresis (PFGE). The 11 chromosomes are designated by Roman numerals Ib, Ia, II to X, and range in size from approximately 1.8 Mb to >10 Mb (the present limit that can be determined by PFGE; Ref. 9) . Because the karyotype is consistent with the genetic linkage analysis, it is likely that all of the chromosomes have been isolated and identified, and that there is only a small amount of observed interstrain chromosomal polymorphism. Comparisons of the karyotypes of representatives of the three major clonal lineages show very little chromosomal size variation; furthermore, the karyotypes appear to be highly stable, revealing no apparent difference during ten years of continual passage (Refs 9, 32; Fig. 3 ).
Compared with other protozoans, including related apicomplexans such as Plasmodium falciparum, T. gondii maintains a remarkably conserved nuclear genome despite a wide host range and nonobligatory sexual cycle. This property of the T. gondii genome will facilitate the pilot genomic sequencing project that is concentrated on chromosome Ib (J. Ajioka and the Sanger Centre, Cambridge, UK, unpublished), and future efforts to identify genes, open reading frames (ORFs), intron-exon boundaries, upstream cis-acting promoter elements, and so on. In turn, the inter-strain differences between genes and/or ORFs should provide us with insight into the associated variation in disease pathology.
Gene expression
Current evidence suggests that gene expression in T. gondii is transcriptionally regulated (Refs 33, 34, 35, 36) . Unlike in other protozoan parasites such as Trypanosoma spp. and Leishmania spp., polycistronic transcription and RNA editing Toxoplasma gondii genomics: shedding light on pathogenesis and chemotherapy 6 expert reviews in molecular medicine have not been detected. Although conventional cis-acting eukaryotic promoters such as the TATA box or SP1 motif have not been observed, upstream sequence analysis of several genes has identified a common highly conserved T/AGAGACG heptanucleotide core element (Refs 34, 35, 36; Table 1 ).
The upstream regions of genes coding for five highly abundant proteins -the surface antigen SAG1 and the four dense-granule proteins GRA1, GRA2, GRA5 and GRA6 -have been analysed for promoter and/or transcription initiator activity (Refs 34, 35) . SAG1 is a single-copy gene containing no introns and has two transcriptional 
EST analysis
For organisms with relatively large nuclear genomes, including T. gondii, EST analysis is a faster and more cost-effective method for generating DNA sequence information than a genomic approach. An EST approach comparing strains and developmental stages has proved to be a useful method for elucidating the processes that differ between the acute and chronic infection. 
ESTs and gene expression
Because ESTs are generated from a randomly selected set of cDNAs, differences in gene expression between strains and developmental stages might be revealed. has revealed a 6.3 kb transcript in ME49 that is not seen in RH. Although these data suggest that EST numbers roughly correlate with cellular gene expression, it should be remembered that cloning bias, random sampling and sequencing error are likely to affect the statistics in a sample of this magnitude, and probably account for most of the observed differences.
The encysted bradyzoite stage of T. gondii, a hallmark of the chronic infection, is much less well characterised than the active tachyzoite stage owing to the relative difficulty in obtaining sufficient material from mouse brain tissue cysts. However, with the discovery of culturing procedures to trigger the differentiation of in vitro tachyzoites into bradyzoites (e.g. alkaline culture media), this problem has been partially resolved (Ref. 45 Table 3 ). The genes with a constitutive expression pattern show relatively low variation, and the greatest difference between tachyzoites and bradyzoites is less than fourfold. Among the five stage-specific proteins reported, three ESTs are absolutely different (i.e. not sampled in the opposing stage), whereas abundance of the other two differs over tenfold. This analysis also revealed other stage-specific ESTs, including tachyzoite-and bradyzoite-specific forms of enolase. The stagespecific expression patterns of enolases support the hypothesis that the glycolytic pathway is different between the two stages (Ref. 47) . Despite the fact that these strain and developmental EST abundance comparisons appear to identify reliably only genes with very large expression differences, they are a useful first approximation Toxoplasma gondii genomics: shedding light on pathogenesis and chemotherapy 10 expert reviews in molecular medicine 12) . Some of these proteins had even been described in T. gondii, but the genes encoding them had not been reported. This was particularly evident for the protein components of the organelles that participate in the active invasion process that is common to all apicomplexans. For example, the subcellular fractionation of T. gondii micronemes identified a set of proteins that are secreted during attachment to the host cell (Refs 49, 50). Studies in Eimeria tenella and P. falciparum revealed a similar set of proteins, including E. tenella Etp100 (Ref. 51) and P. falciparum TRAP (Ref. 52 ). Furthermore, a database search of T. gondii ESTs showed that the putative EST tg050 product had striking similarity to the thrombospondin (TSP) or TSP-like adhesion domains of Etp100 and TRAP (Ref. 53 ). Full-length cDNA and genomic sequence established the major ORF, intron-exon structure and transcriptional initiation site with putative promoter elements. The sequence alignment and domain analysis with Etp100 suggested that they are orthologous genes or proteins and are members of a family of apicomplexan adhesion molecules including TRAP. The tg050 recombinant protein was shown to cross-react with antisera raised against the T. gondii microneme protein MIC2, providing conclusive evidence that the EST tg050 sequence encodes a microneme protein. The discovery of the SAG paralogues SRS2, SRS3 and SRS4 confirmed the conservation of these structural features; overall amino acid identities to SAG1 are about 30%. These results support the idea that the family members are under selective pressure to maintain a particular secondary structure and some functional redundancy, yet might have divergent biological roles. The expression of SRS2 and SRS3 appears to be restricted to tachyzoites, and the virulent RH strain (Type I) shows little expression of SRS2 compared with abundant expression on the nonvirulent ME49 (Type II) and CEP (Type III) strains. The domination of the parasite surface by a single protein family whose members can be expressed differentially between strains and developmental stages suggests that functional and immunological studies of SAG and SRS proteins will provide significant insight into their roles in the acute and chronic infection (Ref. 56) 
Apicoplast proteins
Given the limited coding capacity of the apicoplast 35 kb genome, most of the apicoplast proteins must be encoded by the nucleus and imported to the organelle (J.C. Kissinger et al., pers. commun.; GenBank accession number U87145; http://www.sas.upenn.edu/~jkissing/ toxomap.html). Discounting plastid proteins that are not thought to function in the apicoplast (e.g. photosynthetic proteins), as many as 800 proteins may be imported into the organelle (Ref .  57) ; however, more-recent estimates suggest that 100-200 is a more likely number (J.C. Kissinger, pers. commun.). Defining common features among apicoplast proteins (e.g. N-terminal transit peptides for entry into the organelle) is essential for computer-assisted identification of these proteins from primary sequence data (Ref. 58 ; http://www.sas.upenn.edu/~jkissing/ wh99.html). In turn, this set of proteins should reveal the function(s) of the apicoplast.
As a result of the evolutionary origins of the apicoplast, which involved a secondary endosymbiotic event and retention of four unit membranes, imported apicoplast proteins have two additional membranes to cross compared with plastids of higher plants or algae (see below). This observation has suggested that a plastid transit peptide would be necessary but probably not sufficient for import into the organelle. Evidence including the direct observation that the secretory pathway is used for protein routing in organisms that have complex (multimembranous) plastids (Ref. 59) has raised the possibility that a similar pathway could be employed by apicomplexans. Organelle protein synthesis and class II fatty acid metabolism are two functions that are characteristic of plastids, so it was hypothesised that ribosomal proteins and proteins in the fatty acid synthesis pathway might be imported into the apicoplast (Ref. 13) . BLAST analysis of the T. gondii ESTs uncovered homologues for ribosomal proteins S9 and L28 and two fatty acid biosynthetic enzymes, namely acyl carrier protein (ACP) and β-hydroxyacyl-ACP dehydrogenase (FabZ). The full-length sequence of the corresponding cDNAs revealed what appeared to be long bipartite leader peptides composed of a classical signal peptide followed by a putative transit peptide. The molecular phylogenies of T. gondii ribosomal proteins S9 and L28 argue that they are bacterial or plastid in nature (Ref. 13) , so analysis of their gene structure could reveal how they acquired elements crucial for their expression in the nucleus and subsequent transport to the apicoplast. The gene transfer from the ancestral plastid genome must have involved a duplicate copy of each gene being inserted into the nucleus, and the acquisition of elements for nuclear expression and targeting sequences for import into the organelle (reviewed in Refs 60, 61). Although it is possible to select from a pool of random sequences to promote transcription (see for example Ref. 62) 63) , data indicate that the acquisition of preexisiting functional sequences is a more-effective mechanism. The gene structure of the nucleusencoded chloroplast rpl22 gene suggests that its transit peptide was acquired via exon shuffling (Refs 64, 65). The maize rps14 gene has achieved a similar result by alternative splicing after integration into the intron of the nucleus-encoded mitochondrial protein gene sdh2 (Refs 66, 67). Both T. gondii rps9 and rpl28 genes show splice junctions adjacent to the leader sequence. Given that these proteins are plastid encoded in algae (Ref. 68 ), an analysis of 5' upstream sequences could provide clues as to the nature and timing of the plastidto-nucleus transfer. The identification and characterisation of more nucleus-encoded genes and/or proteins targeted to the apicoplast will undoubtedly lead to a better understanding of its origin and function.
The apicoplast: origins, function and chemotherapy
The retention of the apicoplast throughout the phylum Apicomplexa suggests an essential function for the plastid-like organelle within the parasite. The lack of this unusual organelle in the vertebrate host makes it an attractive chemotherapeutic target. Defining the origin and taxonomic relationships of the apicoplast and its 35 kb genome is crucial for understanding the action of some currently used drugs, as well as the potential development of herbicidebased drugs and the discovery of new drug targets. Although our understanding of the apicoplast is derived from studies in a variety of apicomplexan species, the attributes of T. gondii as a model system have made it indispensable for investigating this curious organelle.
Discovery of the apicoplast
The connection between the apicoplast organelle and its genome is a historically interesting story because the molecular evidence from the genome led to the re-discovery of the organelle (reviewed in Refs 69, 70 
Evolutionary history
Deciphering the evolutionary history of the apicoplast is not only of intrinsic interest, but could also provide clues to which plastid metabolic pathways are retained in the organelle, which pathways have been transferred to the cytosol (either as replacement or redundant functions) and which pathways have been lost. Ultimately, the raison d' être of this organelle could be assessed.
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The apicoplast, like all other plastids, originated from a primary endosymbiotic event with a cyanobacterial-like prokaryote, resulting in the characteristic two-membrane organelle that is found in higher plants and both red and green algae (reviewed in Refs 69, 78) . Evidence suggests that this primary endosymbiont was subsequently transferred into several existing eukaryotic lineages (Ref. 78) . These secondary endosymbionts are characterised by organelles that have either three or four membranes, and one of these secondary endosymbiotic events founded the lineage that includes the Apicomplexa. Phylogenetic analyses of nucleusencoded 18S rRNA genes indicate a monophyletic origin of apicomplexans and dinoflagellates (see for example Refs 79, 80, 81) . Although dinoflagellates include members that have multimembranous plastids, direct comparisons with these species must be made with care because secondary endosymbiotic events probably occurred many times within the group (Ref. 82). Nevertheless, these phylogenetic and ultrastructural observations support the view that the apicoplast was acquired through secondary endosymbiosis of an alga, and further analyses of nucleus-encoded apicoplast genes are likely to increase our understanding of the origins of this organelle.
Independent evidence from phylogenies of the tufA gene (which encodes an elongation factor) associates the apicoplast with green algae (Ref. 77) . By contrast, the apicoplast genome structure is more like that of red algae. The ribosomal protein genes s12 and s7, and the tufA gene, are found at the 3' end of the operon, as in red algae; contrastingly, these genes are found at the 5' end in green algae (Ref. 69) . The apicoplast also retains the ycf24 and clpC genes, which are both found in red algae but not in green algae (Ref. 83) . However, the mapping of chloroplast gene loss across an inferred tree of unicellular and multicellular organisms has shown that independent parallel gene losses in multiple lineages far outnumbered phylogenetically unique losses (Ref. 68) . This suggests that these types of data probably will not satisfactorily resolve the basis of the original secondary endosymbiotic event. However, in spite of this conundrum, there is a strong collection of evidence to suggest that the apicoplast is a bona fide plastid that has some kind of algal origin.
Apicoplast function and chemotherapy
The apicoplast provides an ideal target for drug treatment because of its bacterial or plastid origin and the possible maintenance of metabolic pathways not found in animals. The complete T. gondii 35 kb apicoplast DNA sequence appears to include genes encoding both largeand small-subunit rRNAs, RNA polymerase genes, the elongation factor tufA gene, tRNA (transfer RNA) genes, a putative ribosomal protein gene operon and five ORFs of unknown function (J.C. Kissinger et al., pers. commun.; GenBank accession number U87145; http:// www.sas.upenn.edu/~jkissing/toxomap.html). This analysis suggests that the apicoplast maintains the capacity for gene expression; however, most of the functional proteins are encoded in the nucleus and imported into the organelle (see section entitled 'Apicoplast proteins'). The investigations into apicoplast functions have been intimately associated with both defining the action of currently used drugs and searching for new chemotherapeutic targets based on plastid function in plants and algae. Although the apicoplast does not appear to encode proteins for DNA replication, the replication mechanism(s) could include a theta and/or a rolling circle process (Ref. 85 
Conclusions
Genomic studies of both nuclear and apicoplast DNA of T. gondii have become the cornerstone for new investigations into both pathogenesis and chemotherapy. EST and related genetic information have provided key data to increase our understanding of virulence factors and differences between strains and clonal lineages. Although the primary sequence analysis of the 35 kb DNA does not give any direct evidence for the specific function(s) of the apicoplast, the retention of transcription and translation machinery suggests that the apicoplast is a functioning organelle, and this machinery might be targeted by currently used parasiticidal drugs. The movement of genes such as ACP and FabZ from the plastid genome to the nuclear genome through evolutionary time suggests that the identification of nucleus-encoded genes with homology to cyanobacterial and/or plastid genes will ultimately reveal both apicoplast and other plastid-like functions in the parasite. The interplay between basic biological investigations such as genomic analysis and those targeted at chemotherapy is essential to the development of more-effective drug treatments for toxoplasmosis and other apicomplexan-related disease. Tables   Table 1. Upstream repeated motif sequences of Toxoplasma gondii genes (tab001jac). Table 2 . Summary of abundant expressed sequence tags (ESTs) from both RH (total ESTs 5359) and ME49 (total ESTs 1806) tachyzoite cDNA libraries (tab002jac). Table 3 . Summary of abundant expressed sequence tags (ESTs) from an ME49 tachyzoite cDNA library (total ESTs 1806) and an ME49 bradyzoite cDNA library (total ESTs 2353) (tab003jac).
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